EU approves Takeda buying Shire, on divestment condition
November 20, 2018 at 09:12 AM EST
The European Commission said on Tuesday that it approved the $62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.
